16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone

16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone

Independent Study Guide Notice: Independent study guide by OpenExamPrep. This educational resource is developed independently by OpenExamPrep and is not sponsored, endorsed, or affiliated with the National Board of Podiatric Medical Examiners (NBPME) or Meazure Learning.

Hypothalamic-Pituitary Axis: Embryology & Architecture

The pituitary gland (hypophysis cerebri) sits within the sella turcica of the sphenoid bone, immediately inferior to the optic chiasm. It comprises two developmentally, morphologically, and functionally distinct divisions:

                  Embryological Duality of the Pituitary Gland

     ORAL CAVITY ROOF (Stomodeum)            FLOOR OF DIENCEPHALON
     [Oral Ectoderm]                         [Neuroectoderm]
            │                                       │
            ▼ Upgrowth                              ▼ Downgrowth
      Rathke Pouch                             Infundibulum
            │                                       │
            ▼                                       ▼
     ANTERIOR PITUITARY                      POSTERIOR PITUITARY
     (Adenohypophysis)                       (Neurohypophysis)
     - Glandular Epithelial Cells            - Axons from Supraoptic (ADH) &
     - Hypophyseal Portal Venous System        Paraventricular (Oxytocin) Nuclei
     - Hormones: TSH, ACTH, FSH,             - Stored in HERRING BODIES
       LH, GH, Prolactin                     - Supported by PITUICYTES

1. Anterior Pituitary (Adenohypophysis)

• Embryological Derivation: Arises from an upward invagination of oral ectoderm from the roof of the primitive stomodeum termed Rathke's pouch. A persistent vestige of Rathke's pouch can give rise to a craniopharyngioma (a benign suprasellar tumor in children presenting with bitemporal hemianopsia and calcifications on imaging).
• Vascular Control: Regulated by hypothalamic releasing and inhibiting hormones transported through the hypophyseal portal venous system (capillary plexus of the median eminence $\rightarrow$ portal venules $\rightarrow$ secondary capillary plexus of adenohypophysis).
• Secretory Cell Lineages & Hormones:
  • Corticotropes: Synthesize Adrenocorticotropic Hormone (ACTH), cleaved from the massive precursor polypeptide Pro-opiomelanocortin (POMC) along with $\beta$-endorphin and Melanocyte-Stimulating Hormone ($\alpha$-MSH).
  • Thyrotropes: Synthesize Thyroid-Stimulating Hormone (TSH). Composed of a common glycoprotein $\alpha$-subunit (shared identically with LH, FSH, and hCG) and a unique $\beta$-subunit that confers receptor specificity.
  • Gonadotropes: Synthesize Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).
  • Somatotrope Cells: Synthesize Growth Hormone (GH / Somatotropin). Acts via a transmembrane JAK-STAT receptor tyrosine kinase to stimulate hepatic synthesis and secretion of Insulin-Like Growth Factor 1 (IGF-1 / Somatomedin C), which drives epiphyseal chondrocyte proliferation and longitudinal bone growth.
  • Lactotropes: Synthesize Prolactin. Uniquely under tonic hypothalamic inhibition by Dopamine acting via pituitary $D_2$ receptors. Antipsychotics (dopamine receptor antagonists) block this inhibition, causing hyperprolactinemia, galactorrhea, and amenorrhea.

2. Posterior Pituitary (Neurohypophysis)

• Embryological Derivation: Arises from a downward evagination of neuroectoderm from the ventral diencephalon (hypothalamus), remaining physically connected to the brain via the infundibular stalk.
• Cellular Morphology: Does not synthesize hormones; instead, it consists of unmyelinated nerve terminal axons and supporting specialized glial cells termed pituicytes.
• Hormone Storage & Release:
  • Antidiuretic Hormone (ADH / Vasopressin): Synthesized in cell bodies of the hypothalamic supraoptic nucleus.
  • Oxytocin: Synthesized in cell bodies of the hypothalamic paraventricular nucleus.
  • Both peptide hormones are packaged into neurosecretory granules bound to carrier proteins termed neurophysins, transported down the hypothalamo-hypophyseal tract via fast axonal transport, and stored in dilated terminal axon dilations known as Herring bodies in the posterior lobe prior to exocytosis.

Thyroid Physiology & Clinical Pathology

                  Thyroid Hormone Biosynthesis in Follicular Cell

     BASOLATERAL (Blood)        FOLLICULAR CELL              APICAL (Colloid Lumen)
     ───────────────────        ───────────────              ──────────────────────
     2 Na+ ══► [NIS] ══► I- ──────────────────────────────► [Pendrin] ══► I-
     (Sodium-Iodide Symporter)                                      │
                                                                    ▼
                                                             THYROID PEROXIDASE
                                                             (TPO) [Oxidation]
                                                                    │
                                                                    ▼
                                                            I° or I+ (Active Iodine)
                                                                    │
                                                             + Thyroglobulin (Tg)
                                                                    ▼
                                                             ORGANIFICATION
                                                             MIT and DIT formed
                                                                    │
                                                             TPO COUPLING
                                                             - MIT + DIT = T3
                                                             - DIT + DIT = T4
                                                                    │
     CIRCULATION ◄═════════════ LYSOSOMAL PROTEOLYSIS ◄═════ ENDOCYTOSIS
     T4 (prohormone, 90%)       cleaves Tg to release T4/T3   of colloid droplets
     T3 (active form, 10%)
           │
           ▼ [5'-Deiodinase in liver/kidneys]
     ACTIVE T3 (Binds Nuclear Thyroid Receptor)

Biosynthetic Steps of Thyroid Hormones

1. Iodide Trapping: Dietary iodide ($I^-$) is actively cotransported across the basolateral follicular membrane via the $Na^+/I^-$ Symporter (NIS), utilizing the steep chemical gradient generated by the $Na^+/K^+$ ATPase. (Competitively inhibited by anions: perchlorate, pertechnetate, thiocyanate).
2. Apical Iodide Efflux: Iodide is transported across the apical membrane into the follicular colloid lumen via pendrin ($I^-/Cl^-$ exchanger).
3. Oxidation & Organification: Thyroid Peroxidase (TPO), a heme enzyme situated on the apical membrane, oxidizes iodide ($I^-$) into reactive neutral iodine ($I^0$). TPO then immediately organifies the iodine by iodinating tyrosine residues within thyroglobulin (Tg), forming Monoiodotyrosine (MIT) and Diiodotyrosine (DIT).
4. Coupling: TPO catalyzes the covalent coupling of iodotyrosine residues on the thyroglobulin scaffold: $\text{MIT} + \text{DIT} \longrightarrow \text{Triiodothyronine (T3)}$ $\text{DIT} + \text{DIT} \longrightarrow \text{Thyroxine (T4)}$
   • Pharmacologic Inhibition: Thionamides (Propylthiouracil [PTU] and Methimazole) inhibit TPO, blocking both organification and coupling.
5. Colloid Endocytosis & Secretion: Under TSH stimulation, pseudopodia endocytose colloid droplets. Lysosomes fuse with droplets, and acid proteases cleave T3 and T4 from thyroglobulin, releasing free hormones into the circulation in a ~20:1 ratio (T4 > T3).
6. Peripheral Conversion (5'-Deiodinase): T4 is a prohormone. In peripheral tissues (liver, kidneys, skeletal muscle), the outer ring iodine is removed by 5'-deiodinase to generate biologically active T3 (which has 4-5 times higher affinity for the nuclear thyroid hormone receptor than T4). 5'-deiodinase is inhibited by Propylthiouracil (PTU), $\beta$-blockers (propranolol), systemic corticosteroids, and amiodarone.

Physiological Actions of Thyroid Hormones (T3)

• Basal Metabolic Rate (BMR): Increases transcription and membrane expression of $Na^+/K^+$ ATPase pumps, accelerating cellular oxygen consumption, ATP turnover, and caloric heat production (calorigenic effect).
• Cardiovascular Dynamics: Upregulates myocardial $\beta_1$-adrenergic receptors and sarcoplasmic reticulum $Ca^{2+}$-ATPase (SERCA), increasing resting heart rate, stroke volume, myocardial contractility, and cardiac output.
• Neurodevelopment & Bone: Essential for fetal brain development, myelinogenesis, and synaptogenesis; deficiency in early infancy causes irreversible intellectual disability and short stature (congenital hypothyroidism / cretinism). Accelerates chondrocyte maturation in epiphyseal growth plates.

Clinical Thyroid Pathologies: Podiatric Correlations

• Hashimoto Thyroiditis (Chronic Autoimmune Thyroiditis):
  • Most common cause of primary hypothyroidism in the United States.
  • Autoantibodies against Thyroid Peroxidase (anti-TPO) and Thyroglobulin (anti-Tg) destroy thyroid follicles. Histology reveals dense lymphocytic infiltration with well-developed germinal centers and metaplastic eosinophilic follicular cells (Hürthle cells / Askanazy cells).
  • Clinical Manifestations: Cold intolerance, weight gain, constipation, coarse dry skin, and delayed relaxation phase of deep tendon reflexes ("hung-up" Achilles reflex / Woltman sign).
  • Podiatric Correlation: Widespread deposition of hydrophilic glycosaminoglycans (hyaluronic acid) within interstitial connective tissues causes non-pitting myxedema. Swelling within fibro-osseous tunnels precipitates peripheral nerve entrapment neuropathies, specifically Carpal Tunnel Syndrome (median nerve) and Tarsal Tunnel Syndrome (posterior tibial nerve entrapment beneath the flexor retinaculum posterior to the medial malleolus).
• Graves Disease:
  • Most common cause of hyperthyroidism. Autoantibodies (Thyroid-Stimulating Immunoglobulins [TSI] / TRAb) bind and constitutively activate the follicular TSH receptor, driving autonomous hormone synthesis and diffuse goiter.
  • Pathognomonic Manifestations:
    • Graves Ophthalmopathy (Proptosis): Orbital fibroblasts express TSH receptors; autoantibody stimulation triggers cytokine release, hyaluronic acid accumulation, and profound retro-orbital edema, pushing the globe forward.
    • Pretibial Myxedema (Thyroid Dermopathy): Non-pitting, indurated, violaceous, "orange-peel" (peau d'orange) plaques localized over the anterior pretibial surface of the lower leg and dorsal foot.

Adrenal Gland & Endocrine Pancreas

                  Adrenal Gland Zonation & Steroidogenesis

     LAYER                     REGULATOR       PRIMARY HORMONE   FUNCTION (Mnemonic)
     ───────────────────────────────────────────────────────────────────────────────
     CORTEX (Mesoderm):
     1. Zona Glomerulosa (15%)  Angiotensin II  ALDOSTERONE       Salt (Na+ retain, K+ dump)
     2. Zona Fasciculata (75%)  ACTH            CORTISOL          Sugar (Gluconeogenesis, Anti-inflammatory)
     3. Zona Reticularis (10%)  ACTH            DHEA / Androgens  Sex (Secondary sexual traits)
     ───────────────────────────────────────────────────────────────────────────────
     MEDULLA (Neural Crest):    Sympathetic     EPINEPHRINE (80%) Fight or Flight
     Chromaffin Cells           Pre-ganglionic  NOREPINEPHRINE    (Vasoconstriction,
                                (ACh)           (20%)             Bronchodilation)

Adrenal Cortical Zonation: Salt, Sugar, Sex

1. Zona Glomerulosa (Mineralocorticoids): Regulated predominantly by the Renin-Angiotensin-Aldosterone System (RAAS) and extracellular $[K^+]$. Secretes Aldosterone (via aldosterone synthase). Acts on the distal nephron to promote sodium/water retention and potassium/proton secretion.
2. Zona Fasciculata (Glucocorticoids): Regulated by hypothalamic CRH $\rightarrow$ pituitary ACTH. Secretes Cortisol.
   • Metabolic Actions: Stimulates hepatic gluconeogenesis and glycogenolysis; accelerates peripheral skeletal muscle proteolysis and adipose lipolysis (supplying amino acids and glycerol substrates); downregulates GLUT4 translocation, causing peripheral insulin resistance.
   • Anti-Inflammatory & Immunosuppressive Actions:
     1. Induces the transcription of Lipocortin-1 (Annexin A1), which directly binds and inhibits Phospholipase A2 ($PLA_2$). This halts the liberation of arachidonic acid from cell membrane phospholipids, shutting down the downstream synthesis of both prostaglandins/thromboxane (COX pathway) and leukotrienes (5-LOX pathway).
     2. Inhibits Nuclear Factor $\kappa$B (NF-$\kappa$B), blocking the transcription of pro-inflammatory cytokines: IL-1, IL-2, IL-6, and TNF-$\alpha$.
     3. Inhibits leukocyte rolling and extravasation (causes peripheral leukocytosis due to demargination of neutrophils), while inducing apoptosis of T-lymphocytes and eosinophils.
   • Bone & Connective Tissue Actions: Inhibits osteoblast proliferation and matrix synthesis; decreases intestinal $Ca^{2+}$ absorption; accelerates osteoclast bone resorption. Chronic glucocorticoid excess triggers rapid osteoporosis and avascular necrosis (osteonecrosis) of the femoral and talar heads.
3. Zona Reticularis (Androgens): Regulated by ACTH. Secretes Dehydroepiandrosterone (DHEA) and androstenedione.

Adrenal Medulla: Neural Crest Catecholamines

• Chromaffin Cells: Modified postganglionic neuroendocrine cells derived embryologically from the neural crest. Innervated directly by preganglionic sympathetic fibers that release Acetylcholine (ACh) onto nicotinic ($N_N$) receptors.
• Catecholamine Synthesis: $\text{Tyrosine} \xrightarrow{\text{Tyrosine Hydroxylase}} \text{L-DOPA} \xrightarrow{\text{DOPA Decarboxylase}} \text{Dopamine} \xrightarrow{\text{Dopamine } \beta\text{-Hydroxylase}} \text{Norepinephrine} \xrightarrow{\text{PNMT}} \text{Epinephrine}$
• PNMT Upregulation: The terminal conversion of norepinephrine to epinephrine is catalyzed by Phenylethanolamine N-methyltransferase (PNMT). PNMT is uniquely induced and maintained by high concentrations of cortisol draining directly from the adrenal cortex through intra-adrenal portal sinusoids!

Adrenocortical Pathologies

• Cushing Syndrome (Hypercortisolism): Central obesity, buffalo hump, moon facies, violaceous abdominal striae, muscle atrophy, osteoporosis, impaired wound healing, hyperglycemia. Most common cause overall is exogenous corticosteroid administration. Cushing Disease refers specifically to an ACTH-secreting anterior pituitary adenoma.
• Primary Adrenal Insufficiency (Addison Disease): Autoimmune destruction of all three adrenal cortical layers. Causes combined deficiency of aldosterone (hypotension, hyponatremia, hyperkalemia, non-anion gap metabolic acidosis) and cortisol (hypoglycemia, fatigue). Loss of cortisol negative feedback induces massive transcription of pro-opiomelanocortin (POMC), generating excess ACTH and $\alpha$-MSH, which bind MC1R on melanocytes to produce pathognomonic cutaneous and mucosal hyperpigmentation (buccal mucosa, skin creases, scar lines).

Endocrine Pancreas: Insulin Kinetics & Action

• Islets of Langerhans: Composed of central $\beta$-cells (65-75%; Insulin, Amylin), peripheral $\alpha$-cells (15-20%; Glucagon), and interspersed $\delta$-cells (3-10%; Somatostatin).
• Insulin Synthesis & C-Peptide: Preproinsulin is synthesized in the rough ER, where the signal sequence is cleaved to form proinsulin. In Golgi secretory granules, proinsulin is cleaved by endopeptidases into mature Insulin (51 amino acids across A and B chains linked by disulfide bonds) and equimolar C-Peptide (Connecting Peptide).
  • Clinical Utility of C-Peptide: Because commercial pharmaceutical insulin preparations contain no C-peptide, measuring serum C-peptide allows clinicians to differentiate endogenous insulin hypersecretion (insulinoma, sulfonylurea use; C-peptide elevated) from surreptitious factitious exogenous insulin injection (C-peptide low or undetectable with high insulin).
• B-Cell Secretion Mechanism: Glucose enters $\beta$-cells via insulin-independent GLUT2 transporters $\rightarrow$ phosphorylated by glucokinase $\rightarrow$ glycolysis and Krebs cycle elevate intracellular $[ATP]/[ADP]$ ratio $\rightarrow$ closes ATP-sensitive $K^+$ channels ($K_{ATP}$) $\rightarrow$ cell membrane depolarizes $\rightarrow$ opens voltage-gated $Ca^{2+}$ channels $\rightarrow Ca^{2+}$ influx triggers insulin exocytosis.
  • Sulfonylureas (glipizide, glyburide) and Meglitinides bind directly to the SUR1 subunit of the $K_{ATP}$ channel, closing it mechanically to stimulate insulin secretion.
• Insulin Signaling Cascade: Insulin binds its transmembrane Receptor Tyrosine Kinase (RTK) $\rightarrow$ autophosphorylation of intracellular $\beta$-subunits $\rightarrow$ recruitment and phosphorylation of Insulin Receptor Substrates (IRS-1, IRS-2) $\rightarrow$ activation of the PI3K / Akt (Protein Kinase B) pathway $\rightarrow$ stimulates exocytic translocation of GLUT4 glucose transporters to the plasma membrane in skeletal muscle and adipose tissue.
  • Net Actions: Anabolic: drives glycogenesis, lipogenesis, protein translation; strongly stimulates cellular potassium uptake by activating the $Na^+/K^+$ ATPase.

Calcium & Bone Homeostasis

Extracellular calcium ($[Ca^{2+}] \approx 8.5\text{--}10.5 \text{ mg/dL}$, ionized fraction $\sim 4.5\text{--}5.5 \text{ mg/dL}$) and phosphate ($[HPO_4^{2-}] \approx 3.0\text{--}4.5 \text{ mg/dL}$) are tightly coordinated by three primary hormones: Parathyroid Hormone (PTH), Active Vitamin D ($1,25\text{-(OH)}_2\text{-D}_3$ / Calcitriol), and Calcitonin:

                  Systemic Calcium & Phosphate Homeostasis

                               LOW SERUM IONIZED Ca2+
                                         │
                                         ▼ Derepresses CaSR
                                PARATHYROID GLANDS
                                (Chief Cells secrete PTH)
                                         │
            ┌────────────────────────────┼────────────────────────────┐
            ▼                            ▼                            ▼
          BONE                         KIDNEY                       KIDNEY
     Binds Osteoblasts            DCT: Stimulates              PCT: Inhibits NaPi-IIa
     -> Upregulates RANKL         TRPV5 channels               cotransporters
     -> Activates Osteoclasts     -> Reabsorbs Ca2+            -> PHOSPHATURIA
     -> Resorbs Ca2+ & PO43-             │                     (Prevents Ca-PO4 stones)
            │                            │                            │
            │                            ▼                            │
            │                   Upregulates Renal                     │
            │                   1α-Hydroxylase                        │
            │                   (Converts 25-OH-D3                    │
            │                    to 1,25-(OH)2-D3)                    │
            │                            │                            │
            │                            ▼                            │
            │                     SMALL INTESTINE                     │
            │                     Stimulates Calbindin                │
            │                     & TRPV6 transporters                │
            │                     -> Absorbs Ca2+ & PO43-             │
            ▼                            │                            ▼
     ELEVATES SERUM Ca2+ ◄───────────────┴──────────────────► LOWERS SERUM PO43-

1. Parathyroid Hormone (PTH)

• Synthesis & Regulation: Secreted by chief cells of the four parathyroid glands. Chief cells express cell-surface Calcium-Sensing Receptors (CaSR), which are G-protein coupled ($G_q$ and $G_i$). High ionized serum $[Ca^{2+}]$ binds CaSR, activating intracellular pathways that inhibit PTH gene transcription and exocytosis. Conversely, a decrease in ionized calcium derepresses CaSR, triggering rapid PTH release within seconds.
• Actions on Bone (Indirect Osteoclast Activation):
  • Mature osteoclasts do not possess functional PTH receptors!
  • PTH binds G-protein coupled receptors ($G_s \rightarrow cAMP$) on osteoblasts.
  • Osteoblasts respond by upregulating surface expression of RANKL (Receptor Activator of Nuclear Factor $\kappa$B Ligand) and downregulating secretion of Osteoprotegerin (OPG), a soluble decoy receptor for RANKL.
  • RANKL binds the RANK receptor on osteoclast precursor cells of the monocyte/macrophage lineage, driving their fusion, differentiation, and activation into mature multinucleated osteoclasts.
  • Osteoclasts dissolve hydroxyapatite crystals, mobilizing both Calcium and Phosphate into the circulation.
• Actions on the Kidney:
  1. Distal Convoluted Tubule: Directly stimulates active transcellular reabsorption of $Ca^{2+}$ via apical TRPV5 channels and basolateral NCX1 extrusion.
  2. Proximal Convoluted Tubule (Phosphaturia): Inhibits apical sodium-phosphate cotransporters (NaPi-IIa), causing rapid endocytosis and lysosomal degradation of the transporter. This prevents phosphate reabsorption, producing profound phosphaturia. Biochemical Rationale: Because bone resorption releases both calcium and phosphate, phosphate must be eliminated in urine to prevent the calcium-phosphate solubility product ($[Ca^{2+}] \times [PO_4^{3-}]$) from exceeding critical crystallization thresholds that trigger soft-tissue and vascular calcification!
  3. Stimulation of $1\alpha$-Hydroxylase: Upregulates transcription of the renal mitochondrial enzyme $1\alpha$-hydroxylase (CYP27B1) in the PCT, converting inactive calcidiol into active calcitriol.
• Net Serum Effects of PTH: $\uparrow$ Serum Calcium, $\downarrow$ Serum Phosphate, $\uparrow$ Urinary cAMP.

2. Active Vitamin D ($1,25\text{-(OH)}_2\text{-D}_3$ / Calcitriol)

• Metabolic Pathway: $\text{7-Dehydrocholesterol (Skin)} \xrightarrow{\text{UVB Light}} \text{Cholecalciferol (Vit } D_3) \xrightarrow{\text{Liver: 25-Hydroxylase}} 25\text{-(OH)-D}_3 \text{ (Calcidiol)}$ $25\text{-(OH)-D}_3 \xrightarrow{\text{Kidney PCT: 1}\alpha\text{-Hydroxylase (Stimulated by PTH)}} 1,25\text{-(OH)}_2\text{-D}_3 \text{ (Calcitriol)}$
• Primary Intestinal Actions: Calcitriol binds nuclear Vitamin D Receptors (VDR) in duodenal and jejunal enterocytes, acting as a steroid hormone transcription factor to upregulate:
  1. Apical calcium channels (TRPV6).
  2. Intracellular calcium transport chaperone protein (Calbindin-D28k).
  3. Basolateral $Ca^{2+}$-ATPase (PMCA1b) and sodium-phosphate cotransporters.
• Net Serum Effects of Calcitriol: $\uparrow$ Serum Calcium AND $\uparrow$ Serum Phosphate (promotes systemic bone mineralization).

3. Calcitonin

• Secreted by parafollicular C cells of the thyroid gland (derived from neural crest / ultimopharyngeal body) in response to hypercalcemia.
• Directly binds receptors on mature osteoclasts, instantly inactivating their ruffled border and halting bone resorption. (Serves as a tumor marker for medullary thyroid carcinoma).

Clinical Calcium & Osseous Pathologies

1. Primary Hyperparathyroidism: Most commonly caused by a solitary benign parathyroid adenoma (~85%). Hypersecretion of PTH despite elevated calcium.
   • Laboratory Profile: Elevated serum $[Ca^{2+}]$, decreased serum $[PO_4^{3-}]$, elevated intact PTH, elevated urinary cAMP, and elevated 24-hour urinary calcium (high filtered load overwhelms tubular reabsorption).
   • Clinical Presentation ("Stones, Bones, Groans, and Psychiatric Overtones"): Calcium oxalate nephrolithiasis, osteitis fibrosa cystica (subperiosteal cortical resorption, "salt-and-pepper" skull, brown tumors of fibrous tissue and osteoclasts), constipation, peptic ulcer disease (calcium stimulates gastrin), and neuropsychiatric depression.
2. Secondary Hyperparathyroidism: Arises from Chronic Kidney Disease (CKD). Failing kidneys cannot excrete phosphate (causing hyperphosphatemia) and lose functional renal parenchyma containing $1\alpha$-hydroxylase (causing calcitriol deficiency). Resulting hypocalcemia drives chronic, massive compensatory hyperplasia of all four parathyroid glands.
   • Laboratory Profile: High PTH, Low or Normal $[Ca^{2+}]$, High $[PO_4^{3-}]$, low calcitriol. Leads to renal osteodystrophy.
3. Hypoparathyroidism: Arises most frequently from accidental surgical excision of parathyroid glands during total thyroidectomy, or autoimmune polyglandular syndrome 1.
   • Laboratory Profile: Low serum $[Ca^{2+}]$, elevated serum $[PO_4^{3-}]$, low PTH.
   • Clinical Presentation (Hypocalcemic Tetany): Neuromuscular hyper-excitability, perioral paresthesias, carpopedal spasm, Chvostek sign (ipsilateral facial twitching upon tapping the facial nerve anterior to the ear), Trousseau sign (painful carpal spasm elicited by inflating a sphygmomanometer cuff above systolic pressure for 3 minutes), and prolonged QT interval on electrocardiogram (predisposing to torsades de pointes).
4. Vitamin D Deficiency: Rickets & Osteomalacia:
   • Defective mineralization of uncalcified osteoid matrix due to low calcium-phosphate product.
   • Rickets (Pediatric): Affects open epiphyseal growth plates. Chondrocytes in the zone of hypertrophy fail to calcify; unmineralized osteoid accumulates, causing wide, cupped, frayed metaphyses, rachitic rosary of costochondral junctions, craniotabes, and severe weight-bearing bowing deformities of the lower extremities (genu varum or genu valgum).
   • Osteomalacia (Adult): Affects remodeling bone after epiphyseal plate closure. Presents with diffuse bone pain, muscle weakness, and pathognomonic radiolucent cortical fracture lines perpendicular to the long axis of bone (Looser zones / pseudofractures / Milkman lines), frequently observed in the metatarsal shafts, femoral neck, and pelvis.
   • Laboratory Profile: Low $25\text{-(OH)-D}$, low-normal $[Ca^{2+}]$, low $[PO_4^{3-}]$, compensatory elevated PTH, and markedly elevated Alkaline Phosphatase (ALP).

Reproductive Endocrinology

The outline's endocrine heading covers the gonadal axis as well as the pituitary, thyroid, adrenal, pancreatic and calcium hormones.

• Hypothalamic-pituitary-gonadal axis: pulsatile GnRH stimulates anterior pituitary LH and FSH, which act through Gs and cAMP. Continuous GnRH-agonist exposure (leuprolide) downregulates the axis, which is used in prostate cancer and endometriosis.
• Testis:
  • LH stimulates Leydig cells to make testosterone from cholesterol.
  • FSH stimulates Sertoli cells to support spermatogenesis and to secrete inhibin B, which feeds back on FSH, and androgen-binding protein.
  • Testosterone is converted to dihydrotestosterone by 5-alpha-reductase (blocked by finasteride) and to estradiol by aromatase.
• Ovary:
  • In the follicular phase, FSH-driven granulosa cells use aromatase to convert theca-cell androgens into estradiol (the two-cell model).
  • Rising estradiol switches to positive feedback, causing the mid-cycle LH surge and ovulation.
  • The corpus luteum then secretes progesterone.
• Estrogen and bone: estrogen limits osteoclast activity, partly by raising osteoprotegerin and lowering RANKL. The fall in estrogen at menopause accelerates bone loss, which explains postmenopausal osteoporosis and fragility fractures, including metatarsal stress fractures. Estrogen also drives epiphyseal closure in both sexes, so aromatase or estrogen-receptor deficiency causes tall stature with open growth plates.
• Hormone-binding proteins: sex hormone-binding globulin and albumin carry testosterone and estradiol. Only the free fraction is active (17.4).
• Pregnancy: human chorionic gonadotropin maintains the corpus luteum until the placenta takes over progesterone production. Relaxin and estrogen increase ligamentous laxity. Pregnancy also brings edema, weight gain and arch flattening, and it raises the risk of venous thromboembolism.